Blog

Cancer cells are adept at avoiding destruction by the immune system, often exploiting specific pathways to escape detection and elimination. One of these key mechanisms involves the SIRPα-CD47 axis, which prevents macrophages and other phagocytic cells from attacking tumor cells. SIRPα inhibitors, such as P84, are emerging as novel immunotherapies that block this protective signal, allowing the immune system to recognize and engulf cancer cells. This article explores the role of SIRPα inhibition in enhancing phagocytosis, promoting anti-tumor immunity, and the therapeutic potential of anti-SIRPα agents like P84 in cancer treatment. Assay Genie · SIRPα Inhibition Clearing Tu …

CD40, a member of the tumor necrosis factor receptor (TNFR) superfamily, plays a pivotal role in regulating immune responses, particularly in activating antigen-presenting cells (APCs) and promoting T cell activation. Over the past decade, CD40 has emerged as a promising target in cancer immunotherapy due to its ability to stimulate both the innate and adaptive immune systems, driving potent anti-tumor responses. By activating CD40, researchers aim to amplify immune reactions that enhance the immune system’s ability to recognize and destroy cancer cells. This article explores the biology of CD40, its role in anti-tumor immunity, and its potential in cancer immunotherapy.What is …

V-domain Ig suppressor of T cell activation (VISTA) is an emerging immune checkpoint receptor that plays a key role in suppressing T cell activity within the tumor microenvironment (TME). As a negative regulator of immune responses, VISTA helps tumors evade detection by dampening the immune system’s ability to attack cancer cells. Recent research into targeting VISTA has highlighted its potential as a therapeutic target in cancer immunotherapy. By inhibiting VISTA, scientists aim to unleash the full power of T cells and other immune cells to attack and destroy tumors. This article explores VISTA’s function in immune regulation, its role in cancer progression, and the potential o …

B7-H3, also known as CD276, is a member of the B7 family of immune checkpoint molecules that has emerged as a compelling target in tumor immunotherapy. Initially recognized for its role in regulating immune responses, B7-H3 has gained increasing attention due to its overexpression in various cancers and its ability to promote immune evasion. As a result, B7-H3 has become a promising target for cancer immunotherapy, offering new hope for treatments aimed at improving patient outcomes by enhancing the immune system’s ability to fight tumors. AudioAssay Genie · B7-H3: A Promising New Target in Tumor ImmunotherapyWhat is B7-H3? B7-H3 is an immune regulatory molecule expres …

T cell immunoglobulin and mucin-domain containing-3 (TIM-3) is an immune checkpoint receptor that plays a pivotal role in T cell exhaustion, a state where T cells lose their ability to effectively combat cancer or infections. As a result, TIM-3 has gained significant attention as a therapeutic target to enhance immunotherapy outcomes. This article delves into the biological functions of TIM-3, its involvement in T cell exhaustion, and the potential of TIM-3 inhibitors in improving cancer immunotherapy and treatments for chronic diseases.What is TIM-3?TIM-3 is an immune checkpoint receptor expressed on various immune cells, including CD4+ T cells, CD8+ T cells, regulatory T cells …

Glucocorticoid-induced tumor necrosis factor receptor (GITR) is an immune checkpoint molecule that plays a crucial role in regulating T cell activation and survival. In recent years, GITR has emerged as a promising target for cancer immunotherapy due to its ability to enhance immune responses against tumors. By stimulating T cells, particularly effector T cells, and inhibiting the suppressive function of regulatory T cells (Tregs), GITR-based therapies aim to boost the immune system’s ability to attack cancer cells. This article explores the function of GITR in immune regulation and its potential for enhancing cancer immunotherapy.Assay Genie · GITR Boosting T Cell Activation Fo …

Regulatory T cells (Tregs) play a crucial role in maintaining immune balance by suppressing excessive immune responses that could lead to tissue damage. However, in the context of cancer, Tregs can be problematic because they also suppress the immune system’s ability to attack and eliminate tumors. One of the key markers of Tregs is CD25, which is the alpha chain of the IL-2 receptor. This article explores the role of CD25 and Tregs in tumor immunity, shedding light on how these cells contribute to tumor growth and how they can be targeted to improve cancer immunotherapy outcomes.Assay Genie · CD25 And Tregs Understanding The Role Of Regulatory T Cells In Tumor ImmunityWhat Are …

Natural killer (NK) cells are a crucial component of the innate immune system and play a significant role in eliminating tumor cells. Unlike T cells, NK cells can recognize and kill cancer cells without prior sensitization, which makes them particularly valuable in cancer immunotherapy. As research progresses, novel therapies aim to harness and enhance NK cells' innate ability to fight cancer. This article explores NK cells' function, their role in cancer immunosurveillance, and the innovative therapeutic strategies being developed to improve cancer treatment outcomes.Assay Genie · NK Cells: Unlocking the Potential of Natural Killer Cells in Cancer TherapyWhat Are NK Cells?NK ce …

Lymphocyte Activation Gene-3 (LAG-3) is an immune checkpoint receptor that plays a critical role in regulating T cell function. In recent years, LAG-3 has emerged as a potential target for combination therapies aimed at overcoming T cell exhaustion, particularly in the context of cancer immunotherapy. By revitalizing exhausted T cells, LAG-3 inhibitors offer a new avenue for enhancing the efficacy of existing therapies like PD-1 inhibitors. This article explores LAG-3’s role in immune modulation and its potential as a therapeutic target.Understanding T Cell Exhaustion and LAG-3T cell exhaustion is a state in which T cells progressively lose their functionality after prolonged ex …

TIGIT (T cell immunoreceptor with Ig and ITIM domains) has emerged as a promising target in cancer immunotherapy and the treatment of autoimmune diseases. As a checkpoint receptor, TIGIT plays a critical role in regulating immune responses by inhibiting the activity of immune cells, especially T cells and natural killer (NK) cells. By manipulating TIGIT pathways, scientists aim to develop therapies that enhance immune responses against cancer or dampen harmful immune activity in autoimmune disorders.Understanding TIGIT's Role in Immune RegulationTIGIT belongs to the immunoglobulin superfamily and is primarily expressed on T cells, including regulatory T cells (Tregs), activated …

CD4+ T cells are central to the immune system, functioning as coordinators of immune responses and regulators of immune tolerance. These cells are divided into two primary subtypes: Helper T cells (Th cells) and Regulatory T cells (Tregs). Both subsets of CD4+ T cells perform distinct roles, influencing the immune system's ability to attack pathogens or suppress excessive immune activity. Understanding the specialized functions of these cells sheds light on their importance in diseases such as infections, autoimmune disorders, and cancer.Assay Genie · CD4+ T Cells Unveiling The Role Of Helper And Regulatory T CellsCD4+ T Cells: Structure and DifferentiationCD4+ T cells are a sub …

Cancer immunotherapy has revolutionized the treatment landscape for various malignancies. One of the most promising therapeutic strategies is the use of immune checkpoint inhibitors, particularly anti-PD-1 (programmed death-1) antibodies. These drugs enhance the immune system's ability to recognize and destroy cancer cells by restoring the function of T cells, which are often suppressed in cancer patients.Assay Genie · Anti-PD-1: Restoring T Cell Function in Cancer ImmunotherapyIntroduction to PD-1 and Its Role in Immune EvasionPD-1 is an immune checkpoint receptor expressed on T cells. It plays a critical role in maintaining immune homeostasis by preventing overactivation of T …

Immunotherapy has revolutionized cancer treatment by harnessing the body's immune system to fight malignancies. Among the notable advancements in this field is the development of immune checkpoint inhibitors. One of the key players is anti-CTLA-4 (cytotoxic T-lymphocyte-associated protein 4), a monoclonal antibody that disrupts immune checkpoints and enhances T cell activation. Anti-CTLA-4 has shown immense promise, especially when used in combination immunotherapy. This article delves into how anti-CTLA-4 works, its role in unleashing the power of T cells, and its synergistic effects in combination therapies.Assay Genie · Anti - CTLA - 4 Unleashing The Power Of T Cells In Combi …

CD8+ T cells, also known as cytotoxic T lymphocytes (CTLs), are a critical component of the immune system. They play a vital role in defending the body against viral infections, intracellular pathogens, and tumor cells. This article will delve into the biology of CD8+ T cells, their mechanisms of action, and their clinical relevance, particularly in immunotherapy and infectious disease control.Assay Genie · CD8+ T Cells Understanding The Role Of Cytotoxic T Cells In ImmunityWhat Are CD8+ T Cells?CD8+ T cells are a subset of T lymphocytes that express the CD8 glycoprotein on their surface. This marker distinguishes them from other T cells, such as CD4+ helper T cells. CD8+ T cell …

SfN 2024: Meet Assay Genie at the Society for NeuroscienceAssay Genie is delighted to be attending SfN 2024 in Chicago, Illinois on 5th to the 9th of October at the McCormick Convention Centre.At Assay Genie we take pride in working with some of world's leading Neuroscientists investigating the pathways involved in regulating neuronal activity, so it will be our pleasure to meet researchers attending this year's SfN 2024 convention.This year we have worked on and launched numerous antibodies focussed on immune checkpoints to support research in this space so we will be delighted to discuss all things cancer-related at SfN 2024.If you get a chance to drop by we will have some As …

IntroductionCancer cells have developed sophisticated mechanisms to evade the immune system, particularly through the inhibition of T-cell responses. One such mechanism involves the programmed death-ligand 1 (PD-L1), which binds to its receptor PD-1 on T cells, leading to the suppression of immune activity. Anti-PD-L1 therapies, as part of the broader category of immune checkpoint inhibitors, have transformed cancer treatment by restoring immune system function and enhancing the body's ability to recognize and eliminate tumor cells. This article explores the role of PD-L1 in immune evasion and how its inhibition can significantly impact cancer therapy outcomes.Assay Genie · Anti …

AACR 2025: Meet Assay Genie at the American Association for Cancer Research Assay Genie is delighted to be attending and exhibiting at AACR 2025 in Chicago, Illinois from the 25-30th of April 2025.At Assay Genie we take pride in working with some of world's leading Cancer Researching investigating the pathways involved in activating and blocking cancer, so it will be our pleasure to meet researchers attending AACR 2025 convention.This year we have worked on and launched numerous antibodies focussed on immune checkpoints to support research in this space so we will be delighted to discuss all things cancer-related at the AACR.If you get a chance to drop by we will have some …

SITC 2024: Meet Assay Genie at the Society for Immunotherapy of Cancer Annual MeetingAssay Genie is delighted to be attending and exhibiting at SITC 2024 in Houston, Texas on Friday the 9th and Saturday the 12th of November.At Assay Genie we take pride in working with some of world's leading immunologists investigate the pathways involved in activating and blocking cancer, so it will be our pleasure to meet researchers attending this year's 2024 SITC convention.This year we have worked on and launched numerous antibodies focussed on immune checkpoints to support research in this space so we will be delighted to discuss all things cancer-related at SITC 2024.If you get a chance …

Glucagon-like peptide-1 (GLP-1) is a critical hormone in the regulation of glucose metabolism and has garnered significant attention due to its therapeutic potential in managing diabetes and obesity. Understanding the biological role of GLP-1 provides insights into its mechanisms of action and its impact on various physiological processes.Introduction to GLP-1GLP-1 is an incretin hormone primarily produced in the L-cells of the small intestine in response to food intake. It plays a pivotal role in enhancing insulin secretion from the pancreas, a process crucial for maintaining glucose homeostasis. GLP-1 is derived from the proglucagon gene and exists in two main forms, GLP-1(7-3 …

Th17 cells, a subset of T helper cells characterized by their production of interleukin-17 (IL-17), play a significant role in the immune system's response to pathogens and in the pathology of autoimmune diseases. This article delves into the mechanisms of Th17 cell differentiation, exploring the interplay of cytokines, transcription factors, and their implications for health and disease. Initiation of Th17 Differentiation: The Cytokine Prelude The Role of TGF-β and IL-6 Th17 differentiation begins with the orchestration of specific cytokines, notably transforming growth factor-beta (TGF-β) and interleukin-6 (IL-6). TGF-β sets the stage for a bifurcated pathway that can le …

Dublin, Ireland — May 20th 2024 — Assay Genie, a leading supplier of ELISA Kits, Antibodies, Cellular Assays, and In Vivo Monoclonal Antibodies, is pleased to announce partnerships with three new distributors across the Middle East and Asia. The newly appointed distributors are AFMS in Saudi Arabia, Biotechno Labs in India, and Lab-A-Porter in Hong Kong and Macau. These strategic partnerships mark a significant milestone in Assay Genie's ambitious growth plan, aiming to become one of the foremost suppliers in the biotechnology industry. With the addition of these new partners, Assay Genie now has distribution agreements in 10 countries across Asia and a total of 66 countries …

Introduction Tumorigenesis, the process by which normal cells transform into cancer cells, is a multifaceted and complex event influenced by various internal and external factors. Among these, growth factors play a pivotal role in cellular communication and regulation, often being the critical elements that can tip the balance towards cancer development when dysregulated. This article delves into how growth factors, through their intricate network and interactions, can cooperate to promote tumorigenesis, highlighting the mechanisms behind their action and the implications for cancer therapy. The Role of Growth Factors in Cell Regulation Growth factors are proteins that bin …

Inflammasomes are complex intracellular structures that play a pivotal role in the immune response by detecting pathogenic microorganisms and sterile stressors. Their activation is a critical step in the host defense system, leading to the maturation and secretion of pro-inflammatory cytokines like IL-1β and IL-18. This article provides a detailed examination of the mechanisms underlying inflammasome activation. Understanding the Inflammasome: Structure and Function Inflammasomes are multiprotein oligomers, primarily composed of a sensor (typically a pattern recognition receptor), the adaptor protein ASC, and the effector protein pro-caspase-1. The most well-studied inflammasomes …

Acetylation, a chemical process characterized by the addition of an acetyl functional group to a molecule, stands as a cornerstone in both biochemical and biological landscapes. Its significance traverses diverse realms, ranging from fundamental cellular processes to intricate disease pathogenesis. This article endeavors to delve deeper into the multifaceted world of acetylation, exploring its intricate mechanisms, diverse functions, and far-reaching implications in health and disease. Chemistry of Acetylation: Acetylation, at its essence, involves the transfer of an acetyl group (-COCH3) to a substrate molecule, a process catalyzed by enzymes known as acetyltransferases. T …